Psychometric Properties Upper Limb Function Measures Multiple Sclerosis
Launched by HASSELT UNIVERSITY · Jan 12, 2015
Trial Information
Current as of August 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • diagnosis of MS according to McDonald criteria
- • a treatment goal to maintain or improve upper limb function
- • no relapse within the last month
- • no changes in disease modifying medication and no corticoid-therapy within the last month
- • receive at least 10 sessions of physical or occupational therapy (in- or outpatient rehabilitation), with a maximum duration of 3 months
- Exclusion Criteria:
- • other medical conditions interfering with mobility (e.g. stroke, pregnancy, fractures, ...)
- • other neurological impairments with permanent damage (stroke, Parkinson, ...)
- • MS-like syndromes such as neuromyelitis optica
- • not able to understand and execute simple instructions
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Diepenbeek, , Belgium
Patients applied
Trial Officials
Peter Feys, prof. dr.
Principal Investigator
Hasselt University
Ilse Baert, dr.
Study Chair
Hasselt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials